8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
Feb 26, 2026·SEC
Material company update
Nov 6, 2025·SEC
Alpha Teknova, Inc.(TKNO)Earnings, Financials & Key Ratios
TKNO•NASDAQ
$5.43
Price updated Jul 7, 2026
SectorHealthcareIndustrySpecialty & Generic PharmaSub-IndustryContract development and manufacturing services
AboutAlpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.Show more
- Revenue$41M+7.4%
- EBITDA-$11M+45.7%
- Net Income-$17M+35.5%
- EPS (Diluted)-0.32+43.9%
- Gross Margin33.17%+73.2%
- EBITDA Margin-26.24%+49.4%
- Operating Margin-41.9%+39.5%
- Net Margin-42.59%+39.9%
- ROE-22.83%+26.4%
TKNO Price & Volume
Alpha Teknova, Inc. (TKNO) stock price & volume — 10-year historical chart
Loading chart...
Persistent Operating Losses Threaten Liquidity Runway
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Mixed
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Imminent liquidity and dilution
Key Thesis Takeaways
- Alpha Teknova faces a precarious financial outlook characterized by structural operating losses and a rapidly depleting cash position that has fallen to $4.3 million as of 2026Q1.
- While the company maintains specialized manufacturing capabilities, the inability to scale revenue beyond $11.1 million per quarter against high fixed overhead suggests a fundamental disconnect in its business model.
- Investors should remain cautious as the firm's reliance on equity-based compensation and potential future financing needs may lead to significant shareholder dilution.
Verdict Logic
the company's cash runway has dwindled to $4.3 million, and the persistent negative free cash flow margin of -32.3% suggests an imminent risk of dilutive capital raises.
TKNO Growth Metrics
Alpha Teknova, Inc. (TKNO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years5.3%
3 Years-0.73%
TTM9.29%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM26.29%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM35.24%
Return on Capital
10 Years-15.17%
5 Years-22.21%
3 Years-22.31%
Last Year-16.68%
TKNO Recent Earnings
Alpha Teknova, Inc. (TKNO) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 6, 2026Metric
Actual
Est
EPS
$0.08+13.6%
$0.09
Rev
$11M+8.3%
$10M
Q1 2026
Feb 26, 2026Metric
Actual
Est
EPS
$0.09+0.0%
$0.09
Rev
$10M+3.0%
$10M
Q4 2025
Nov 6, 2025Metric
Actual
Est
EPS
$0.08+14.7%
$0.09
Rev
$10M+8.7%
$10M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$0.07+30.3%
$0.10
Rev
$10M+3.9%
$10M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $0.08vs $0.09+13.6% | $11Mvs $10M+8.3% |
| Q1 2026 | Feb 26, 2026 | $0.09vs $0.09+0.0% | $10Mvs $10M+3.0% |
| Q4 2025 | Nov 6, 2025 | $0.08vs $0.09+14.7% | $10Mvs $10M+8.7% |
| Q3 2025 | Aug 7, 2025 | $0.07vs $0.10+30.3% | $10Mvs $10M+3.9% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Alpha Teknova, Inc. (TKNO)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $5.43 | $291.1M | -16.97 | 7.35% | -42.59% | -22.83% | — | |
| $25.37 | $1.17B | -20.80 | 3.55% | -29.86% | -10.69% | — | |
| $58.25 | $8.87B | -388.33 | 2.08% | -0.34% | -0.5% | — | |
| $281.27 | $40.28B | -185.05 | 35.9% | -9.05% | -15.13% | — | |
| $1.56 | $484.54M | -0.86 | 3.89% | -80.34% | -488.45% | — | |
| $21.02 | $596.98M | -10.67 | 13.83% | -23.04% | -6.74% | — |
Compare TKNO vs Peers
Alpha Teknova, Inc. (TKNO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
TKNO SEC Filings & Documents
Alpha Teknova, Inc. (TKNO) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when TKNO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
TKNO Frequently Asked Questions
Alpha Teknova, Inc. (TKNO) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Alpha Teknova, Inc.'s revenue?
Alpha Teknova, Inc. (TKNO) reported $41.8M in revenue for fiscal year 2025. This represents a 108% increase from $20.1M in 2019.
How fast is Alpha Teknova, Inc. growing?
Alpha Teknova, Inc. (TKNO) grew revenue by 7.4% over the past year. This is steady growth.
Is TKNO profitable?
Alpha Teknova, Inc. (TKNO) reported a net loss of $17.2M for fiscal year 2025.
Dividend & Returns
What is TKNO's return on equity?
Alpha Teknova, Inc. (TKNO) has a return on equity (ROE) of -22.8%. Negative ROE indicates the company is unprofitable.
What is Alpha Teknova, Inc.'s free cash flow?
Alpha Teknova, Inc. (TKNO) had negative free cash flow of $8.9M in fiscal year 2025, likely due to heavy capital investments.